Covered recipient · General Payments record
GITI ROSTAMI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,354.66
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $473.54 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $158.75 | 9 |
| Janssen Biotech, Inc. | $115.83 | 5 |
| GENZYME CORPORATION | $59.68 | 2 |
| QOL Medical, LLC | $36.70 | 1 |
| Gilead Sciences, Inc. | $34.32 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.80 | 2 |
| Celgene Corporation | $21.35 | 1 |
| Ardelyx, Inc. | $17.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.60 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979287 | CMS |
| ABBVIE INC. | $14.38 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979289 | CMS |
| ABBVIE INC. | $24.20 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979291 | CMS |
| ABBVIE INC. | $18.19 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979293 | CMS |
| ABBVIE INC. | $19.48 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979295 | CMS |
| ABBVIE INC. | $18.50 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979297 | CMS |
| ABBVIE INC. | $15.90 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979299 | CMS |
| ABBVIE INC. | $18.37 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979301 | CMS |
| ABBVIE INC. | $15.13 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105979303 | CMS |
| Ardelyx, Inc. | $17.11 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146704734 | CMS |
| Celgene Corporation | $21.35 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101126558 | CMS |
| GENZYME CORPORATION | $32.70 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897146 | CMS |
| GENZYME CORPORATION | $26.98 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897178 | CMS |
| Gilead Sciences, Inc. | $16.96 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133782560 | CMS |
| Gilead Sciences, Inc. | $17.36 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133782562 | CMS |
| Janssen Biotech, Inc. | $24.35 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078520030 | CMS |
| Janssen Biotech, Inc. | $16.20 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078519901 | CMS |
| Janssen Biotech, Inc. | $17.67 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078519927 | CMS |
| Janssen Biotech, Inc. | $27.87 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078520338 | CMS |
| Janssen Biotech, Inc. | $29.74 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078520023 | CMS |
| QOL Medical, LLC | $36.70 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147719917 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.55 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137664986 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.25 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137664988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.